Nuwellis, Inc. - Common Stock (NQ:NUWE)

4.720 -0.550 (-10.44%)

Delayed Quote Updated: 12:35 PM EST, Nov 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Nuwellis, Inc. - Common Stock

Sphere 3D (NASDAQ: ANY) Advances AI Data Center Expansion as Hopkinsville, KY Weighs New Regulations

July 30, 2026

Via AB Newswire

Topics Artificial Intelligence

Oversold Stocks ANY, DFNS, TOON, NUWE, Watch Now!

July 30, 2026

Via AB Newswire

Nuwellis Inc. (NASDAQ: NUWE) Surges on Pediatric Cardiorenal Expansion as Oversold Stocks Take Center Stage – See Inside

July 30, 2026

Via AB Newswire

JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live

July 22, 2025

Via ACCESS Newswire

Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030

December 30, 2022

EQNX::TICKER_START (NASDAQ:SILO),(NASDAQ:BXRX),(NASDAQ:HOTH),(NASDAQ:KALA),(NASDAQ:NUWE) EQNX::TICKER_END

Via FinancialNewsMedia

Nuwellis (NASDAQ: NUWE) Reports Clinical Data Showing 100% Survival Rate Using Ultrafiltration in High-Risk CABG Patients

August 31, 2022

Nuwellis, Inc. (NASDAQ: NUWE) is engaged as a medical device company, which is focused on the development and commercialization of

Via Spotlight Growth

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.